Acurion’s team brings together award-winning scientists, highly cited oncologists, and seasoned life science leaders—uniting deep expertise to advance access to precision therapies for all cancer patients.
Rick Fultz
CEO
Ludmil B. Alexandrov, Ph.D.
CTO, Co-Founder
Feng Cao, Ph.D.
COO
Erik N. Bergstrom, Ph.D.
CTO
Shelly Vandertie
Financial Consultant
Magda Marquet, Ph.D.
Board Chair, Co-Founder
François Ferre, Ph.D.
Board Member, Co-Founder
Scott M. Lippman, M.D.
Board Member, Co-Founder
Webster Cavenee, ph.D.
Board Member, Co-Founder
Gene Dantsker, Ph.D.
Scientific Advisor
J. Silvio Gutkind, Ph.D.
Scientific Advisor
William n. William, Ph.D.
Scientific Advisor
Teresa Davoli, Ph.D.
Scientific Advisor
Jim Abbruzzese, Ph.D.
Scientific Advisor
Let's move cancer care forward – together.
Explore how Acurion is driving immediate precision for optimal care. Contact us for a demo of OncoGaze™.